Trial intelligence / Profile preview

Beta-Blockers and Aspirin Effects on Stress-Induced Hemostasis

NCT00174902Phase 2Unknown

Sponsor
ETH Zurich
Start
Oct 2003
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of propranolol, aspirin in atherosclerosis, sponsored by ETH Zurich. Status: unknown.

02

Drugs

propranololaspirin
03

Conditions

atherosclerosis

Beyond the preview

Go deeper on NCT00174902.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00174902.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call